Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 466

1.

Diffuse Large B-Cell Lymphoma Version 1.2016.

Zelenetz AD, Gordon LI, Wierda WG, Abramson JS, Advani RH, Andreadis CB, Bartlett N, Byrd JC, Fayad LE, Fisher RI, Glenn MJ, Habermann TM, Lee Harris N, Hernandez-Ilizaliturri F, Hoppe RT, Horwitz SM, Kaminski MS, Kelsey CR, Kim YH, Krivacic S, LaCasce AS, Lunning M, Nademanee A, Porcu P, Press O, Rabinovitch R, Reddy N, Reid E, Roberts K, Saad AA, Sokol L, Swinnen LJ, Vose JM, Yahalom J, Zafar N, Dwyer M, Sundar H.

J Natl Compr Canc Netw. 2016 Feb;14(2):196-231.

PMID:
26850490
2.

2 Gy × 2 for palliative treatment of mantle cell lymphoma.

White EC, Advani R, Hoppe RT.

Leuk Lymphoma. 2016 Jan 14:1-3. [Epub ahead of print] No abstract available.

PMID:
26763352
3.

Are Advanced Radiation Therapy Technologies Required for Treating Patients With Hodgkin Lymphoma?

Hoppe RT.

J Natl Compr Canc Netw. 2016 Jan;14(1):2-3. No abstract available.

PMID:
26733550
4.

Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model.

Scarisbrick JJ, Prince HM, Vermeer MH, Quaglino P, Horwitz S, Porcu P, Stadler R, Wood GS, Beylot-Barry M, Pham-Ledard A, Foss F, Girardi M, Bagot M, Michel L, Battistella M, Guitart J, Kuzel TM, Martinez-Escala ME, Estrach T, Papadavid E, Antoniou C, Rigopoulos D, Nikolaou V, Sugaya M, Miyagaki T, Gniadecki R, Sanches JA, Cury-Martins J, Miyashiro D, Servitje O, Muniesa C, Berti E, Onida F, Corti L, Hodak E, Amitay-Laish I, Ortiz-Romero PL, Rodríguez-Peralto JL, Knobler R, Porkert S, Bauer W, Pimpinelli N, Grandi V, Cowan R, Rook A, Kim E, Pileri A, Patrizi A, Pujol RM, Wong H, Tyler K, Stranzenbach R, Querfeld C, Fava P, Maule M, Willemze R, Evison F, Morris S, Twigger R, Talpur R, Kim J, Ognibene G, Li S, Tavallaee M, Hoppe RT, Duvic M, Whittaker SJ, Kim YH.

J Clin Oncol. 2015 Nov 10;33(32):3766-73. doi: 10.1200/JCO.2015.61.7142. Epub 2015 Oct 5.

PMID:
26438120
5.

Evaluation of the International Prognostic Score (IPS-7) and a Simpler Prognostic Score (IPS-3) for advanced Hodgkin lymphoma in the modern era.

Diefenbach CS, Li H, Hong F, Gordon LI, Fisher RI, Bartlett NL, Crump M, Gascoyne RD, Wagner H Jr, Stiff PJ, Cheson BD, Stewart DA, Kahl BS, Friedberg JW, Blum KA, Habermann TM, Tuscano JM, Hoppe RT, Horning SJ, Advani RH.

Br J Haematol. 2015 Nov;171(4):530-8. doi: 10.1111/bjh.13634. Epub 2015 Sep 7.

PMID:
26343802
6.

Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project.

Kim YH, Tavallaee M, Sundram U, Salva KA, Wood GS, Li S, Rozati S, Nagpal S, Krathen M, Reddy S, Hoppe RT, Nguyen-Lin A, Weng WK, Armstrong R, Pulitzer M, Advani RH, Horwitz SM.

J Clin Oncol. 2015 Nov 10;33(32):3750-8. doi: 10.1200/JCO.2014.60.3969. Epub 2015 Jul 20.

PMID:
26195720
7.

Hodgkin Lymphoma: the Changing Role of Radiation Therapy in Early-Stage Disease—the Role of Functional Imaging.

Iberri DJ, Hoppe RT, Advani RH.

Curr Treat Options Oncol. 2015 Sep;16(9):45. doi: 10.1007/s11864-015-0360-6.

PMID:
26187795
8.

A single-institution retrospective analysis of outcomes for stage I-II primary mediastinal large B-cell lymphoma treated with immunochemotherapy with or without radiotherapy.

Binkley MS, Hiniker SM, Wu S, Natkunam Y, Mittra ES, Advani RH, Hoppe RT.

Leuk Lymphoma. 2015 Sep 28:1-5. [Epub ahead of print]

PMID:
26159046
9.

Imaging Shock Waves in Diamond with Both High Temporal and Spatial Resolution at an XFEL.

Schropp A, Hoppe R, Meier V, Patommel J, Seiboth F, Ping Y, Hicks DG, Beckwith MA, Collins GW, Higginbotham A, Wark JS, Lee HJ, Nagler B, Galtier EC, Arnold B, Zastrau U, Hastings JB, Schroer CG.

Sci Rep. 2015 Jun 18;5:11089. doi: 10.1038/srep11089.

10.

XVIII. Management of nodular lymphocyte predominant Hodgkin lymphoma.

Advani RH, Hoppe RT.

Hematol Oncol. 2015 Jun;33 Suppl 1:90-5. doi: 10.1002/hon.2226. Review. No abstract available.

PMID:
26062064
11.

Sbi00515, a Protein of Unknown Function from Streptomyces bingchenggensis, Highlights the Functional Versatility of the Acetoacetate Decarboxylase Scaffold.

Mueller LS, Hoppe RW, Ochsenwald JM, Berndt RT, Severin GB, Schwabacher AW, Silvaggi NR.

Biochemistry. 2015 Jun 30;54(25):3978-88. doi: 10.1021/acs.biochem.5b00483. Epub 2015 Jun 18.

PMID:
26039798
12.

Hodgkin lymphoma, version 2.2015.

Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Bello CM, Benitez CM, Bierman PJ, Blum KA, Chen R, Dabaja B, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Huang J, Johnston PB, Khan N, Maloney DG, Mauch PM, Metzger M, Moore JO, Morgan D, Moskowitz CH, Mulroney C, Poppe M, Rabinovitch R, Seropian S, Tsien C, Winter JN, Yahalom J, Burns JL, Sundar H; National comprehensive cancer network.

J Natl Compr Canc Netw. 2015 May;13(5):554-86.

PMID:
25964641
13.

Biological characterization of stage I follicular lymphoma according to extranodal or nodal primary origin and t(14;18) status using high-resolution array-based comparative genomic hybridization.

Weinberg OK, Ma L, Hoppe RT, Arber DA.

Am J Hematol. 2015 Aug;90(8):E151-2. doi: 10.1002/ajh.24050. Epub 2015 May 29. No abstract available.

PMID:
25963736
14.

Randomized Phase III Trial Comparing ABVD Plus Radiotherapy With the Stanford V Regimen in Patients With Stages I or II Locally Extensive, Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the North American Intergroup E2496 Trial.

Advani RH, Hong F, Fisher RI, Bartlett NL, Robinson KS, Gascoyne RD, Wagner H Jr, Stiff PJ, Cheson BD, Stewart DA, Gordon LI, Kahl BS, Friedberg JW, Blum KA, Habermann TM, Tuscano JM, Hoppe RT, Horning SJ.

J Clin Oncol. 2015 Jun 10;33(17):1936-42. doi: 10.1200/JCO.2014.57.8138. Epub 2015 Apr 20.

PMID:
25897153
15.

Value of surveillance studies for patients with stage I to II diffuse large B-cell lymphoma in the rituximab era.

Hiniker SM, Pollom EL, Khodadoust MS, Kozak MM, Xu G, Quon A, Advani RH, Hoppe RT.

Int J Radiat Oncol Biol Phys. 2015 May 1;92(1):99-106. doi: 10.1016/j.ijrobp.2015.01.039.

PMID:
25863757
16.

Management of nodular lymphocyte predominant Hodgkin lymphoma in the modern era.

King MT, Donaldson SS, Link MP, Natkunam Y, Advani RH, Hoppe RT.

Int J Radiat Oncol Biol Phys. 2015 May 1;92(1):67-75. doi: 10.1016/j.ijrobp.2015.02.001.

PMID:
25863755
17.

Expert radiation oncologist interpretations of involved-site radiation therapy guidelines in the management of Hodgkin lymphoma.

Hoppe BS, Hoppe RT.

Int J Radiat Oncol Biol Phys. 2015 May 1;92(1):40-5. doi: 10.1016/j.ijrobp.2015.02.008.

PMID:
25863752
18.

Modern radiation therapy for primary cutaneous lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group.

Specht L, Dabaja B, Illidge T, Wilson LD, Hoppe RT; International Lymphoma Radiation Oncology Group.

Int J Radiat Oncol Biol Phys. 2015 May 1;92(1):32-9. doi: 10.1016/j.ijrobp.2015.01.008.

19.

Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group.

Yahalom J, Illidge T, Specht L, Hoppe RT, Li YX, Tsang R, Wirth A; International Lymphoma Radiation Oncology Group.

Int J Radiat Oncol Biol Phys. 2015 May 1;92(1):11-31. doi: 10.1016/j.ijrobp.2015.01.009.

20.

The Paris conference "La Radiothérapie de la Maladie de Hodgkin": a first step in the cure of Hodgkin disease.

Hoppe RT, Rosenberg SA.

Int J Radiat Oncol Biol Phys. 2015 May 1;92(1):3-4. doi: 10.1016/j.ijrobp.2015.01.027. No abstract available.

PMID:
25863747
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk